Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.200
-0.040 (-3.23%)
Mar 27, 2026, 11:51 AM EDT - Market open
Pulmonx Market Cap
Pulmonx has a market cap or net worth of $50.68 million as of March 27, 2026. Its market cap has decreased by -82.60% in one year.
Market Cap
50.68M
Enterprise Value
38.99M
1-Year Change
-82.60%
Ranking
Category
Stock Price
$1.20
Market Cap Chart
Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $1.33B to $50.68M, a decrease of -96.20%. That is a compound annual growth rate of -44.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 52.37M | -42.54% |
| Dec 31, 2025 | 91.16M | -66.00% |
| Dec 31, 2024 | 268.12M | -45.11% |
| Dec 29, 2023 | 488.43M | 54.88% |
| Dec 30, 2022 | 315.36M | -73.31% |
| Dec 31, 2021 | 1.18B | -52.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sensus Healthcare | 69.47M |
| LENSAR | 66.65M |
| Outset Medical | 64.64M |
| electroCore | 54.08M |
| Envoy Medical | 52.60M |
| Spectral AI | 49.01M |
| Elutia | 47.92M |
| Accuray | 46.02M |